articleTop 1% cited
A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
Radiotherapy and Oncology · 1997 · Vol. 44(2) · pp. 123–136
Stanley Dische✉(Mount Vernon Hospital)Michele I. Saunders(Mount Vernon Hospital)Ann Barrett(Western Infirmary)A Harvey(Medical Research Council)Delia Gibson(Medical Research Council)Mahesh Parmar(Medical Research Council)
Head and Neck Cancer StudiesOral health in cancer treatmentAdvanced Radiotherapy TechniquesMedicineMucositisRadiation therapyHead and neck cancerSurgeryLarynxCancerHead and neckStage (stratigraphy)Internal medicine
MeSH terms
AdultAgedAged, 80 and overFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedRadiotherapy
Citations
472
FWCI
41.12
field-weighted impact
References
23
Percentile
100%
vs. same field & year
Citations per year
Cited by
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
Radiotherapy and Oncology · 1998 · 563 citations
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
Radiotherapy and Oncology · 2003 · 1,199 citations
Consequential late effects in normal tissues
Radiotherapy and Oncology · 2001 · 439 citations
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
Radiotherapy and Oncology · 1999 · 482 citations
References
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.